Craft
  • Home
  •  / Century Therapeutics
Century Therapeutics

Century Therapeutics

Market Capitalization

$526.7 M

2022-09-20

Century Therapeutics Summary

Company summary

Overview
Century Therapeutics is a biotech company that develops therapies to treat cancer. It develops an allogeneic cell therapy platform that includes induced pluripotent stem cells to incorporate multiple transgenes and remove target genes. The company produces immune effector cell products that target solid tumors and hematological cancer.
Type
Public
Founded
2018
HQ
Philadelphia, PA, US | view all locations
Website
https://www.centurytx.com/
Cybersecurity rating
Sectors

Key people

  • Lalo Flores
  • Hy Levitsky

    Hy Levitsky, President of Research & Development

  • Luis Borges

    Luis Borges, Chief Scientific Officer

  • Greg Russotti

    Greg Russotti, Chief Technology Officer

LocationsView all

3 locations detected

  • Philadelphia, PA HQ

    United States

    3675 Market St

  • Seattle, WA

    United States

    188 E Blaine St

  • Hamilton, ON

    Canada

    270 Longwood Rd S

Century Therapeutics Financials

Summary financials

Revenue (Q2, 2022)
$1.4M
Net income (Q2, 2022)
($31.0M)
Cash (Q2, 2022)
$112.8M
EBIT (Q2, 2022)
($31.4M)
Enterprise value
$429.0M

Footer menu